TY - JOUR
T1 - The relationship of eosinophil granule proteins to ions in the sputum of patients with cystic fibrosis
AU - Halmerbauer, G.
AU - Arri, S.
AU - Schierl, M.
AU - Strauch, E.
AU - Koller, D. Y.
N1 - Copyright:
Copyright 2007 Elsevier B.V., All rights reserved.
PY - 2000
Y1 - 2000
N2 - Background Increased sputum levels of eosinophil granule proteins have been reported despite normal eosinophil numbers in peripheral blood and in the lung in cystic fibrosis (CF). Mechanisms of eosinophil priming and activation are still unclear in CF. Objective In the present study we investigated whether ion concentrations in the sputa of CF patients are related to eosinophil activity. Methods We assessed concentrations of eosinophil cationic protein (ECP), eosinophil protein X (EPX), major basic protein (MBP) and ions (Na+, Cl-, Ca2+Mg2+ in sputum samples of 29 children with CF as well as in 10 controls with bronchial asthma. Results Patients with CF demonstrated significantly higher levels of ECP, Na+, Cl- and Ca2+ levels than asthmatics (P < 0.04, P < 0.0001, P < 0.0001, P < 0.02). No differences were seen between concentrations of EPX and Mg2+ in the two groups. In CF, eosinophil granule proteins correlated significantly with Ca2+ and Mg+ concentrations (ECP, P < 0.0001, r = 0.65, P < 0.0001, r = 0.66; MBP, P < 0.03, r = 0.41, P < 0.03, r = 0.42), furthermore inversely with Cl- concentrations (ECP, P < 0.0003, r = - 0.63; EPX, P < 0.02, r = - 0.45; MBP, P < 0.03, r = - 0.41) but not with Na+ levels. ECP, Na+ and Cl- were also correlated with lung function variables (FVC, P < 0.04, r = - 0.38, P < 0.02, r = 0.44, P < 0.03, r = 0.41; FEV1, P < 0.007, r = - 0.49, P < 0.006, r = 0.5, P < 0.008, r = 0.48; MEF50, P < 0.003, r = - 0.54, NS, P < 0.03, r = 0.42; MEF25, P < 0.039, r = - 0.4, P < 0.005, r = 0.51, P < 0.05, r = 0.37). Conclusion Our results demonstrated a significant relationship of eosinophil degranulation and ions in CF, indicating that ion composition in CF sputa may be at least partly be responsible for high levels of eosinophil products despite low eosinophil numbers.
AB - Background Increased sputum levels of eosinophil granule proteins have been reported despite normal eosinophil numbers in peripheral blood and in the lung in cystic fibrosis (CF). Mechanisms of eosinophil priming and activation are still unclear in CF. Objective In the present study we investigated whether ion concentrations in the sputa of CF patients are related to eosinophil activity. Methods We assessed concentrations of eosinophil cationic protein (ECP), eosinophil protein X (EPX), major basic protein (MBP) and ions (Na+, Cl-, Ca2+Mg2+ in sputum samples of 29 children with CF as well as in 10 controls with bronchial asthma. Results Patients with CF demonstrated significantly higher levels of ECP, Na+, Cl- and Ca2+ levels than asthmatics (P < 0.04, P < 0.0001, P < 0.0001, P < 0.02). No differences were seen between concentrations of EPX and Mg2+ in the two groups. In CF, eosinophil granule proteins correlated significantly with Ca2+ and Mg+ concentrations (ECP, P < 0.0001, r = 0.65, P < 0.0001, r = 0.66; MBP, P < 0.03, r = 0.41, P < 0.03, r = 0.42), furthermore inversely with Cl- concentrations (ECP, P < 0.0003, r = - 0.63; EPX, P < 0.02, r = - 0.45; MBP, P < 0.03, r = - 0.41) but not with Na+ levels. ECP, Na+ and Cl- were also correlated with lung function variables (FVC, P < 0.04, r = - 0.38, P < 0.02, r = 0.44, P < 0.03, r = 0.41; FEV1, P < 0.007, r = - 0.49, P < 0.006, r = 0.5, P < 0.008, r = 0.48; MEF50, P < 0.003, r = - 0.54, NS, P < 0.03, r = 0.42; MEF25, P < 0.039, r = - 0.4, P < 0.005, r = 0.51, P < 0.05, r = 0.37). Conclusion Our results demonstrated a significant relationship of eosinophil degranulation and ions in CF, indicating that ion composition in CF sputa may be at least partly be responsible for high levels of eosinophil products despite low eosinophil numbers.
KW - Bronchial asthma
KW - Cystic fibrosis
KW - Eosinophil granule proteins
KW - Lung function
KW - Sputum ions
KW - Eosinophil Granule Proteins
KW - Chlorides/analysis
KW - Ribonucleases/analysis
KW - Humans
KW - Ions/analysis
KW - Magnesium/analysis
KW - Male
KW - Calcium/analysis
KW - Blood Proteins/analysis
KW - Eosinophil-Derived Neurotoxin
KW - Cystic Fibrosis/immunology
KW - Sputum/immunology
KW - Sodium/analysis
KW - Adolescent
KW - Female
KW - Eosinophils/immunology
KW - Child
UR - http://www.scopus.com/inward/record.url?scp=0034536252&partnerID=8YFLogxK
U2 - 10.1046/j.1365-2222.2000.00988.x
DO - 10.1046/j.1365-2222.2000.00988.x
M3 - Article
C2 - 11122216
SN - 0954-7894
VL - 30
SP - 1771
EP - 1776
JO - Clinical and Experimental Allergy
JF - Clinical and Experimental Allergy
IS - 12
ER -